Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07137273 · ClinicalTrials.gov registry record · NA
Optimizing Dimensions of Reinforcement
A NA study of Autism and Intellectual Disabilities (F70-F79), sponsored by Auburn University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 3
- Study locations
NCT07137273: Recruiting NA study of Autism and Intellectual Disabilities (F70-F79), sponsored by Auburn University.
NCT07137273 is a NA study of Autism and Intellectual Disabilities (F70-F79) that is actively recruiting participants, run by Auburn University. The registered enrollment target is 30 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07137273, a NA study of Autism and Intellectual Disabilities (F70-F79), is actively recruiting participants, sponsored by Auburn University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is designed to better understand how certain features of reinforcement affect learning and motivation in individuals with intellectual and developmental disabilities (IDD). Participants will take part in a series of structured teaching sessions that involve simple tasks and reward-based feedback. By changing the timing and amount of rewards, we aim to learn how these factors influence the ability to acquire and maintain new skills. This information may help improve behavioral interventions for individuals with IDD in the future. The study does not involve medications or procedures intended to change participants' health status.
Primary Outcome
Number of target responses allocated emitted during experimental sessions in which reinforcement parameters (e.g., schedule arrangement, magnitude, and probability) are systematically varied. This measure will be derived from response data recorded during operant conditioning tasks. Changes in allocation patterns will be compared across schedule conditions to assess the effect of reinforcement manipulations.
Conditions Studied
Interventions
- BEHAVIORAL Operant Conditioning Tasks with Reinforcement Manipulations
Study Locations (3)
Alabama
- Center for Autism Research, Treatment, and Training - Auburn
Maryland
- Kennedy Krieger Institute - Baltimore
Michigan
- Oakland University - Rochester Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT07137273 shows while recruiting
NCT07137273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Operant Conditioning Tasks with Reinforcement Manipulations is the first listed.
NCT07137273 reports a single indexed study location in Alabama, Maryland, Michigan.
Frequently Asked Questions
What is clinical trial NCT07137273 about?
NCT07137273 is a clinical study titled "Optimizing Dimensions of Reinforcement". This study is designed to better understand how certain features of reinforcement affect learning and motivation in individuals with intellectual and developmental disabilities (IDD). Participants will take part in a series of structured teaching sessions that involve simple tasks and reward-based f...
What is the current status of trial NCT07137273?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-10-07. Estimated completion is 2026-08.
What conditions does trial NCT07137273 study?
This clinical trial studies the following conditions: Autism, Intellectual Disabilities (F70-F79).
What interventions are being tested in trial NCT07137273?
The interventions under investigation include: Operant Conditioning Tasks with Reinforcement Manipulations (BEHAVIORAL).
Who is sponsoring clinical trial NCT07137273?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07137273 being conducted?
This trial has 3 study locations across Alabama, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07137273's enrollment target sits among peer trials
30 73rd of 104 higher than 29 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI